Effect of soluble vascular endothelial growth factor receptor 1 (sVEGFR1) on growth of human prostate cancer cells in the bone of nude mice

被引：0
|
作者：
Uehara, Hisanori [1 ]
Izumi, Keisuke [1 ]
机构：
[1] Univ Tokushima, Grad Sch, Dept Mol & Environm Pathol, Tokushima 770, Japan
来源：
CLINICAL & EXPERIMENTAL METASTASIS | 2007年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：286 / 286
页数：1
相关论文
共 50 条
  • [31] Antiangiogenic effect of soluble vascular endothelial growth factor receptor-1 in placental angiogenesis
    Ahmad, S
    Ahmed, A
    ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH, 2005, 12 (1-2): : 89 - 95
  • [32] Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells
    Wojta, J
    Kaun, C
    Breuss, JM
    Koshelnick, Y
    Beckmann, R
    Hattey, E
    Mildner, M
    Weninger, W
    Nakamura, T
    Tschachler, E
    Binder, BR
    LABORATORY INVESTIGATION, 1999, 79 (04) : 427 - 438
  • [33] Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients
    Yuan, Jiangzi
    Guo, Qunying
    Qureshi, Abdul Rashid
    Anderstam, Bjorn
    Eriksson, Monica
    Heimburger, Olof
    Barany, Peter
    Stenvinkel, Peter
    Lindholm, Bengt
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (09) : 2356 - 2363
  • [34] Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients
    Kikuchi, Shogo
    Obata, Yuki
    Yagyu, Kiyoko
    Lin, Yingsong
    Nakajima, Toshifusa
    Kobayashi, Osamu
    Kikuichi, Masahiro
    Ushijima, Ryo
    Kurosawa, Michiko
    Ueda, Junko
    CANCER SCIENCE, 2011, 102 (04) : 866 - 869
  • [35] Aberrant methylation of the vascular endothelial growth factor receptor-1 gene in prostate cancer
    Yamada, Y
    Watanabe, M
    Yamanaka, M
    Hirokawa, Y
    Suzuki, H
    Takagi, A
    Matsuzaki, T
    Sugimura, Y
    Yatani, R
    Shiraishi, T
    CANCER SCIENCE, 2003, 94 (06) : 536 - 539
  • [36] Soluble Vascular Endothellal Growth Factor Receptor (sVEGFR-1) Prevents Capillary Growth in Pressure-Overload Hypertrophy
    Scharr, Elisabeth
    Poutias, Dimitrios
    Griffiths, Eric R.
    Barillas, Rodrigo
    Saad, Fawzy A.
    del Nido, Pedro J.
    Friehs, Ingeborg
    CIRCULATION, 2008, 118 (18) : S793 - S794
  • [37] An imbalance between vascular endothelial growth factor and its soluble receptor (sVEGFR-1) in placental villous explants of intrauterine growth restricted pregnancies.
    Crocker, IP
    Padavala, S
    Pope, N
    Brownbill, P
    Baker, PN
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2006, 13 (02) : 103A - 104A
  • [38] Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells
    Bianco, Roberto
    Rosa, Roberta
    Damiano, Vincenzo
    Daniele, Gennaro
    Gelardi, Teresa
    Garofalo, Sonia
    Tarallo, Valeria
    De Falco, Sandro
    Melisi, Davide
    Benelli, Roberto
    Albini, Adriana
    Ryan, Anderson
    Ciardiello, Fortunato
    Tortora, Giampaolo
    CLINICAL CANCER RESEARCH, 2008, 14 (16) : 5069 - 5080
  • [39] Blockade of the vascular endothelial growth factor-receptor 2 pathway inhibits the growth of human renal cell carcinoma, RBM1-IT4, in the kidney but not in the bone of nude mice
    Karashima, Takashi
    Inoue, Kej
    Fukata, Satoshi
    Iiyama, Tatsuo
    Kurabayash, Atsushi
    Kawada, Chiaki
    Shuin, Taro
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 30 (04) : 937 - 945
  • [40] Determination of soluble vascular endothelial growth factor receptor 3 (sVEGFR-3) in plasma as pharmacodynamic biomarker
    Kanefendt, Friederike
    Lindauer, Andreas
    Mross, Klaus
    Fuhr, Uwe
    Jaehde, Ulrich
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 70 : 485 - 491
12345